Objective To ascertain contemporary approaches to the collection, reporting and analysis of
adverse events (AEs) in randomised controlled trials (RCTs) with a primary efficacy …

Acute respiratory distress syndrome (ARDS) occurs when a diverse array of triggers cause
acute, bilateral pulmonary inflammation and increased pulmonary capillary permeability …

Since its first description, the acute respiratory distress syndrome (ARDS) has been
acknowledged to be a major clinical problem in respiratory medicine. From July 2015 to July …

Sepsis-induced acute respiratory distress syndrome (ARDS) has high morbidity and
mortality and arises after lung infection or infection at extrapulmonary sites. An aberrant host …

Beyond haemostasis, platelets have emerged as versatile effectors of the immune response.
The contribution of platelets in inflammation, tissue integrity and defence against infections …

BACKGROUND Whether airspace biomarkers add value to plasma biomarkers in studying
acute respiratory distress syndrome (ARDS) is not well understood. Mesenchymal stromal …

Acute respiratory distress syndrome (ARDS) is a clinical syndrome associated with
oxygenation failure resulting from a direct pulmonary or indirect systemic insult. It is a …

Despite significant advances in our understanding and management of patients with acute
respiratory distress syndrome (ARDS), the morbidity and mortality from ARDS remains high …

Acute respiratory distress syndrome (ARDS) threatens the survival of critically ill patients, the
mechanisms of which are still unclear. Neutrophil extracellular traps (NETs) released by …

Background Scant information exists about the epidemiological characteristics and outcome
of patients in the intensive care unit (ICU) at risk of acute respiratory distress syndrome …